Scrambler Therapy in Chronic Pancreatitis
NCT: NCT07174609 · RECRUITING
Brief Summary
The investigators will enroll adults with chronic pancreatitis who have persistent abdominal pain not relieved by standard treatments. This study will test the feasibility and effectiveness of Scrambler Therapy, a non-invasive FDA-cleared device that delivers "non-pain" electrical signals through the skin to retrain the brain's pain perception. Participants will undergo 5-10 treatment sessions and be followed for 3 months with standardized pain scores and quality-of-life assessments. The goal is to generate pilot data to support larger studies of Scrambler Therapy as a novel option for pancreatic pain.
Frequently Asked Questions
What is Scrambler Therapy in Chronic Pancreatitis?
Scrambler Therapy in Chronic Pancreatitis is a clinical trial registered under NCT07174609. Current status: RECRUITING.
What is the status of NCT07174609?
The current status of NCT07174609 (Scrambler Therapy in Chronic Pancreatitis) is: RECRUITING.
When did Scrambler Therapy in Chronic Pancreatitis start?
Scrambler Therapy in Chronic Pancreatitis started on 2024-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.